Respiratory Muscle Dysfunction in Congestive Heart Failure

Author:

Meyer F. Joachim1,Borst Mathias M.1,Zugck Christian1,Kirschke Andreas1,Schellberg Dieter1,Kübler Wolfgang1,Haass Markus1

Affiliation:

1. From the Department of Cardiology, Angiology, and Respiratory Medicine, Medical Center of the University Heidelberg, Heidelberg, Germany.

Abstract

Background —In congestive heart failure (CHF), the prognostic significance of impaired respiratory muscle strength has not been established. Methods and Results —Maximal inspiratory pressure (Pi max ) was prospectively determined in 244 consecutive patients (207 men) with CHF (ischemic, n=75; idiopathic dilated cardiomyopathy, n=169; age, 54±11 years; left ventricular ejection fraction [LVEF], 22±10%). Pi max was lower in the 244 patients with CHF than in 25 control subjects (7.6±3.3 versus 10.5±3.7 kPa; P =0.001). The 57 patients (23%) who died during follow-up (23±16 months; range, 1 to 48 months) had an even more reduced Pi max (6.3±3.2 versus 8.1±3.2 kPa in survivors; P =0.001). Kaplan-Meier survival curves differentiated between patients subdivided according to quartiles for Pi max ( P =0.014). Pi max was a strong risk predictor in both univariate ( P =0.001) and multivariate Cox proportional hazard analyses ( P =0.03); multivariate analyses also included NYHA functional class, LVEF, peak oxygen consumption (peak V̇ o 2 ), and norepinephrine plasma concentration. The areas under the receiver-operating characteristic curves for prediction of 1-year survival were comparable for Pi max and peak V̇ o 2 (area under the curve [AUC], 0.68 versus 0.73; P =0.28), and they improved with the triple combination of Pi max , peak V̇ o 2 , and LVEF (AUC, 0.82; P =0.004 compared with AUC of Pi max ). Conclusions —In patients with CHF, inspiratory muscle strength is reduced and emerges as a novel, independent predictor of prognosis. Because testing for Pi max is simple in clinical practice, it might serve as an additional factor to improve risk stratification and patient selection for cardiac transplantation.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3